| Catelog# |
Product |
CAS# |
Formula |
Purity(%) |
Inquiry |
First Page Previous Page [2990] [2991] [2992] 2993 [2994] [2995] [2996] [2997] Next Page Last Page Total 77323 items, Total 3093 Page Goto
| 2A-1195638 |
Acetyl Decapeptide-3 |
935288-50-9 |
|
0% |
Inquiry |
| 2A-1195639 |
N2-Acetyl-L-lysyl-L-alpha-aspartyl-L-valyl-L-tyrosine |
757942-88-4 |
|
0% |
Inquiry |
| 2A-1195640 |
PHT-GLY-BETA-ALA-OH |
17896-84-3 |
|
0% |
Inquiry |
| 2A-1195640 |
PHT-GLY-BETA-ALA-OH |
17896-84-3 |
|
0% |
Inquiry |
| 2A-1195641 |
H-LEU-VAL-OH |
13588-95-9 |
|
0% |
Inquiry |
| 2A-1195641 |
H-LEU-VAL-OH |
13588-95-9 |
|
0% |
Inquiry |
| 2A-1195642 |
H-PHE-ALA-OH |
3918-87-4 |
|
0% |
Inquiry |
| 2A-1195643 |
H-VAL-VAL-OH |
3918-94-3 |
|
0% |
Inquiry |
| 2A-1195644 |
H-GLU-TRP-OH |
38101-59-6 |
|
0% |
Inquiry |
| 2A-1195645 |
PALMITOYL GLUTAMIC ACID |
38079-66-2 |
|
0% |
Inquiry |
| 2A-1195646 |
PALMITOYL GLYCINE |
2441-41-0 |
|
0% |
Inquiry |
| 2A-1195647 |
2-[(Carboxymethyl)(dodecyl)amino]acetic acid |
5931-57-7 |
|
0% |
Inquiry |
| 2A-1195648 |
N-LAUROYLSARCOSINE |
97-78-9 |
|
0% |
Inquiry |
| 2A-1195649 |
STE-GLY-OH |
6333-54-6 |
|
0% |
Inquiry |
| 2A-1195650 |
Glycine, N-methyl-, N-coco acyl derivs., sodium salts |
61791-59-1 |
|
0% |
Inquiry |
| 2A-1195651 |
cocoyl glutamic acid |
210357-12-3 |
|
0% |
Inquiry |
| 2A-1195652 |
Glycine, N-coco acyl derivs., sodium salts |
90387-74-9 |
|
0% |
Inquiry |
| 2A-1195653 |
l-Alanine, N-coco acyl derivs., sodium salts |
90170-45-9 |
|
0% |
Inquiry |
| 2A-1195654 |
sodium N-methyl-N-(1-oxotetradecyl)aminoacetate |
30364-51-3 |
|
0% |
Inquiry |
| 2A-1195612 |
DAUNOSAMINE |
4305-54-8 |
C6H13NO3 |
98.00% |
Inquiry |
| 2A-1195690 |
talatisamine |
20501-56-8 |
|
0% |
Inquiry |
| 2A-1195691 |
Euphorbia factor L1 |
76376-43-7 |
|
0% |
Inquiry |
| 2A-1195693 |
ethyl tetrahydro-2H-pyran-2-carboxylate |
110811-34-2 |
|
0% |
Inquiry |
| 2A-1195694 |
(3,4-dihydro-2H-pyran-6-yl)Methanol |
72081-17-5 |
|
0% |
Inquiry |
| 2A-1195695 |
2-BENZYL-2,3-DIHYDRO-1H-PYRROLO[3,4-C]PYRIDINE |
368441-96-7 |
|
0% |
Inquiry |
| |
|
|
|
